placeUnited Kingdom
Contact & Support
Medtronic / Covidien Products / Nociception - Analgesia Management / NOL® Monitoring Technology

Analgesia Optimization

Managing nociception during surgery is a major challenge, impacting patient outcomes, length of stay and cost of treatment.

Excessive use of opioids may result in intraoperative hypotension, respiratory depression, PONV etc.,1,2,3 and underuse of analgesics may promote acute or chronic post-operative pain, delayed recovery and the costs associated with these complications.4,5,6

Our Solution to Monitor Pain

The PMD-200TM nociception monitor, developed by Medasense Ltd., helps you monitor your anaesthetized patients' physiological pain response (nociception) to noxious stimuli and tailor analgesic medications to each patient’s specific sensitivity and needs. The integrated nociception level index (NOL®)  provides superior indication of the presence and severity of pain response vs. individual parameters (such as changes in heart rate and blood pressure) to reduce complications and  improve patient outcomes.7,8

Contact Us

How does Nociception Monitoring work?

1. ACQUIRE     →     2. ANALYZE     →     3. QUANTIFY     →     4. OPTIMAL PAIN CARE

ACQUIRE

The non-invasive platform continuously acquires physicological signals through 4 sensors. Dozens of physiological parameters and derivatives are extracted

ANALYZE

Advanced articificial intelligence algorithms identify the pain-related pattern

QUANTIFY

The information is quantified and visualized with the NOL® index on a scale of 0 (no nociceptive response) to 100 (extreme nociceptive response)

OPTIMAL PAIN CARE

NOL® guides clinicians to ensure optimal pain control while avoiding overmedication

Potential to Reduce Post-Operative Complications

By optimizing analgesic administration in critical care, NOL®-guided analgesia might enhance the patient experience as it reduces the risk of excessive use or underuse of opioids and associated complications.9

Learn More

NOL®-GUIDED ANALGESIA MAY REDUCE INTRAOPERATIVE OPIOID USE BY UP TO 30% WITH 80% FEWER INTRAOPERATIVE HYPOTENSIVE EVENTS9

   

Watch key opinion leaders' experience with NOL®

Dr. Hugo Vereecke: NOL® in the Operating Room 

Prof. Albert Dahan: The NOL® index - A Novel Approach Towards Personalised Analgesia 

Dr. Philippe Richebé: NOL®-Guided Analgesia in the Daily Practice

Would you like to RECEIVE MORE INFORMATION on how pain monitoring with the PMD-200™ can improve the quality of anaesthesia for your patients?

Please complete this form and we will contact you as soon as possible.

View references
Corporate Resources
Medical Surgical Portfolio
Additional Resources
Contact Us
Medtronic Limited

Building 9, Croxley Park

Hatters Lane

Watford, WD18 8WW

United Kingdom

©2022 Medtronic